Ana M. García

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

Donald A. Berry, Mark T. W. Ebbert, Charles M. Perou, 2013, Breast Cancer Research and Treatment.

Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer.

D. Hervás, G. Quintás, A. Santaballa, 2020, European journal of cancer.

Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach.

S. Vadaparampil, T. Pal, Ana M. García, 2011, Genetic testing and molecular biomarkers.

P1-06-04: PAM50 Proliferation Index Predicts Response to Weekly Adjuvant Paclitaxel in Node-Positive Operable Breast Cancer.

C. Perou, I. Stijleman, P. Bernard, 2011 .